Drug Trial Radar · NCT05047601
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
Last checked: Nov 20, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,954
Actual
Start
Sep 9, 2021
Primary completion
Apr 12, 2022
Study completion Apr 12, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 17, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection. All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the experiences of people receiving the study medicines to those of the people who do not. This will help us determine if the study medicines are safe and effective
Conditions
- COVID-19
Interventions
PF-07321332Drug
PF-07321332
Placebo for PF-07321332Drug
Placebo
Placebo for RitonavirDrug
Placebo
RitonavirDrug
Ritonavir
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Developed Symptomatic RT-PCR or RAT Confirmed SARS-CoV-2 Infection Through Day 14: Among Participants With Negative RT-PCR at BaselineTime frame: From Day 1 to Day 14
Locations
170 sites in 17 countries. Site status is shown where the registry gives one.
Cahaba Research Inc
Pelham, Alabama
The Institute for Liver Health dba Arizona Clinical Trials
Tucson, Arizona
Ascada Health PC
Fullerton, California
Optimus Medical Group
San Francisco, California
Synergy Healthcare
Bradenton, Florida
MOORE Clinical Research, Inc.
Brandon, Florida
TrueBlue Clinical Research
Brandon, Florida
Herco Medical and Research Center Inc
Coral Gables, Florida
Advance Clinical Research Group
Cutler Bay, Florida
Beautiful Minds Clinical Research Center
Cutler Bay, Florida
Qway Research
Hialeah, Florida
Eastern Research Inc
Hialeah, Florida
Inpatient Research Clinic
Hialeah, Florida
Doral Medical Research,LLC
Hialeah, Florida
Unlimited Medical Research Group, LLC
Hialeah Gardens, Florida
ASCLEPES Research Centers
Lutz, Florida
Angels Clinical Research Institute
Miami, Florida
LCC Medical Research Institute, LLC
Miami, Florida
Premium Medical Research Corp
Miami, Florida
Global Health Clinical Trials Corp
Miami, Florida
South Florida Research Center, Inc.
Miami, Florida
University of Miami Health System
Miami, Florida
I.V.A.M. Clinical & Investigational Center, LLC
Miami, Florida
Medical Research of Westchester Inc
Miami, Florida
C'A Research
Miami, Florida
ProLive Medical Research, Corp.
Miami, Florida
Entrust Clinical Research
Miami, Florida
Reed Medical Research
Miami, Florida
Kendall South Medical Center, Inc.
Miami, Florida
Clinical Site Partners, Inc dba CSP Miami
Miami, Florida
Coral Research Clinic Corp
Miami, Florida
Pro-Care Research Center, Corp.
Miami Gardens, Florida
Savin Medical Group, LLC
Miami Lakes, Florida
Omega Research Orlando
Orlando, Florida
NAPA Research LLC
Pompano Beach, Florida
CDC Research Institute, LLC
Port Saint Lucie, Florida
USPA Advance Concept Medical Research Group LLC
South Miami, Florida
ASCLEPES Research Centers
Spring Hill, Florida
GCP, Global Clinical Professionals
St. Petersburg, Florida
Sunrise Research Institute
Sunrise, Florida
Showing 40 of 170 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.